Last updated on August 2019

FIRAZYR General Drug Use-Results Survey (Japan)

Brief description of study

The objectives of this survey are to collect data to report the safety and efficacy of Firazyr (Icatibant acetate) in the post-marketing phase in participants diagnosed with Hereditary Angioedema (HAE).

Clinical Study Identifier: NCT04057131

Find a site near you

Start Over


Maebashi, Japan
  Connect »